Caffeine + Placebo
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Energy Expenditure
Conditions
Energy Expenditure
Trial Timeline
Oct 2, 2007 → Apr 21, 2008
NCT ID
NCT00781586About Caffeine + Placebo
Caffeine + Placebo is a approved stage product being developed by Bayer for Energy Expenditure. The current trial status is completed. This product is registered under clinical trial identifier NCT00781586. Target conditions include Energy Expenditure.
Hype Score Breakdown
Clinical
20
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00781586 | Approved | Completed |
Competing Products
1 competing product in Energy Expenditure
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| r-metHuLeptin | Amgen | Phase 1 | 29 |